Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancer

Immune checkpoint inhibitor (ICI) therapy has been less effective in patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations than in patients with EGFR wild-type NSCLC. This retrospective study was conducted to investigate the associations of clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Takeshi, Suzuki, Kensuke, Inomata, Minehiko, Hayashi, Kana, Mizushima, Isami, Tokui, Kotaro, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Masaki, Yasuaki, Taniguchi, Hirokazu, Tobe, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074018/
https://www.ncbi.nlm.nih.gov/pubmed/37035471
http://dx.doi.org/10.3892/mco.2023.2634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074018/
https://www.ncbi.nlm.nih.gov/pubmed/37035471
http://dx.doi.org/10.3892/mco.2023.2634

Ejemplares similares